Elevidys

Generic name: Delandistrogene Moxeparvovec-rokl
Dosage form: suspension for intravenous infusion
Drug class: Miscellaneous uncategorized agents

Usage of Elevidys

Elevidys is a recombinant gene therapy for Duchenne muscular dystrophy (DMD). Elevidys makes it possible for the body to make a protein (Elevidys micro-dystrophin) that contains copies of important sections of dystrophin proteins that were defective in the muscles of patients with Duchenne muscular dystrophy.

Elevidy is given as a single intravenous dose to Duchenne muscular dystrophy patients that are 4 to 5 years old and do not have contraindications to treatment.

Elevidys (Delandistrogene moxeparvovec-rokl) received FDA approval on June 22, 2023, through the Accelerated Approval Pathway.

Elevidys side effects

The most common Elevidys side effects in clinical studies were:

vomiting

nausea

liver function test increased

pyrexia

thrombocytopenia.

The following are clinically significant adverse reactions

acute serious liver injury

immune-mediated myositis

myocarditis.

Relate drugs

How to use Elevidys

The dose of Elevidys is based on body weight. The recommended dose is 1.33 × 1014 vector genomes per kilogram (vg/kg) of body weight (or 10 mL/kg body weight).

Warnings

Acute Serious Liver Injury has been observed when using Elevidys. Before using this medicine liver function test should be performed, then monitor liver function (clinical exam, GGT, and total bilirubin) weekly for the first 3 months following Elevidys infusion.

Immune-mediated Myositis (an immune response affecting muscles). Patients should contact their healthcare provider immediately if they experience any unexplained increased muscle pain, tenderness, or weakness, including swallowing difficulty, difficulty breathing or a weak voice, as these may be symptoms of myositis.

Myocarditis Acute serious myocarditis (inflammation of the heart) and troponin-I elevations have been observed following Elevidys infusion in clinical trials. Patients should contact their healthcare provider immediately if they experience chest pain and/or shortness of breath.

While taking corticosteroids, an infection before or after the Elevidys infusion could lead to more serious complications. Contact a healthcare provider immediately if symptoms suggestive of infection are observed (e.g., coughing, wheezing, sneezing, runny nose, sore throat, or fever).

What other drugs will affect Elevidys

Before starting the corticosteroid regimen required before Elevidys infusion, consider the patient’s vaccination status. Patients should, if possible, be brought up-to-date with all immunizations in current immunization guidelines. Vaccinations should be completed at least 4 weeks before starting the corticosteroid regimen.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.